News

Smith+Nephew Unveils Innovative ALLEVYN COMPLETE CARE Dressing

Smith+Nephew Unveils Innovative ALLEVYN COMPLETE CARE Dressing

New Research on ALLEVYN COMPLETE CARE Dressing

Smith+Nephew, a prominent name in medical technology that trades under the ticker symbols NYSE:SNN and LSE:SN, has announced groundbreaking findings regarding the ALLEVYN COMPLETE CARE Foam Dressing. This innovation is designed to play a pivotal role in the prevention of pressure injuries, a significant issue in healthcare that costs the US system over $26.8 billion annually.

Understanding Pressure Injuries

Pressure injuries, often referred to as bedsores, occur due to prolonged pressure on the skin coupled with shear forces. The new data emphasizes the importance of effective prevention strategies. Professor Amit Gefen and his research team have unveiled through their published study in the International Wound Journal that the ALLEVYN COMPLETE CARE Foam Dressing can absorb 93% of mechanical energy, effectively dissipating harmful shear forces.

The Science Behind the Dressing

Utilizing advanced methodologies such as Frictional Energy Absorber Effectiveness (FEAE) and Finite Element Modelling (FEM), this research thoroughly confirms the unique mechanism by which the ALLEVYN COMPLETE CARE Dressing works. The ability to manage mechanical loading is essential for protecting underlying soft tissues, thereby mitigating the risk of pressure ulcers.

Expert Insights

“These findings represent a significant step forward in pressure injury prevention,” explained Professor Amit Gefen, who holds a position in Biomedical Engineering at Tel Aviv University. “The advanced biomechanical performance of the ALLEVYN COMPLETE CARE Dressing is instrumental in dissipating shear forces, thereby protecting patients from pressure injury risks.”

Industry Impact

Rohit Kashyap, President of Advanced Wound Management at Smith+Nephew, highlights the urgency of addressing pressure injuries: “These injuries pose a complex and costly challenge, which burdens patients and healthcare systems alike. This publication showcases how the ALLEVYN COMPLETE CARE Foam Dressing's unique action can prevent these injuries, promoting better patient outcomes.”

Market Launch and Future Goals

The ALLEVYN COMPLETE CARE Dressing is set to enter the US advanced wound care market soon, with plans for launches in other global markets throughout the following years. The dressing is indicated for the management of diverse wounds and is especially aimed at preventing pressure injuries. Building upon the principles established with the ALLEVYN LIFE Dressing, the new dressing promises enhanced Frictional Energy Absorber Effectiveness, significantly increased from previous models.

Looking Ahead

Foundationally, Smith+Nephew's commitment to innovation drives continuous improvements in patient care and medical technology. The ALLEVYN COMPLETE CARE Dressing is not just a product; it's a leap towards better healthcare strategies that address and manage critical issues associated with pressure injuries.

Frequently Asked Questions

What is the ALLEVYN COMPLETE CARE Dressing?

The ALLEVYN COMPLETE CARE Dressing is a new foam dressing aimed at preventing pressure injuries by effectively absorbing and dissipating shear forces.

Who conducted the research on the ALLEVYN Dressing?

The research was conducted by Professor Amit Gefen and his team, published in the International Wound Journal.

What makes this dressing unique?

It absorbs 93% of mechanical energy, which helps in reducing shear force-related damage, a significant advance over previous designs.

Why are pressure injuries a concern in healthcare?

Pressure injuries can lead to severe complications and financial burdens estimated at over $26.8 billion annually in the US healthcare system.

When will the ALLEVYN COMPLETE CARE Dressing be available?

The dressing will be launched in the US market soon, with additional launches planned in subsequent years across other parts of the world.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 269

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 127

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 59

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
NOTHING NINE's Global Ambitions: Paris Show's Impact

Updated Category News Views 83

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Continue Reading
Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Updated Category News Views 13

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Continue Reading
Superteam Wheels Rides Into Spain with RACEIT Deal

Updated Category News Views 63

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 98

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 81

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
ASICS and University of Michigan Launch Innovation Lab

Updated Category News Views 88

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 412

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

TuHURA Biosciences Advances Phase 3 Trial for Cancer Treatment

Updated Category News Views 229

TuHURA Biosciences Moves Forward with Phase 3 Trial TuHURA Biosciences, Inc. (NASDAQ: HURA) is making substantial strides in the field of cancer immunotherapy. The company is geared up to launch its Phase 3 accelerated approval trial of IFx-2.0, a promising adjunctive therapy in combination with Keytruda (pembrolizumab), targeting advanced and metastatic Merkel cell...

Continue Reading
Fiserv, Inc. Lawsuit: Investors Can Fight Back Against Losses

Updated Category News Views 198

Introduction to the Class Action Lawsuit In recent news, numerous investors in Fiserv, Inc. are being alerted to an important opportunity. A class action lawsuit has been initiated targeting Fiserv, a prominent figure in the financial services tech sector. This situation arises from allegations of significant financial losses endured by shareholders due to the Company's...

Continue Reading
Exploring Humana's Decreased Short Interest and Market Impact

Updated Category News Views 104

Understanding Humana's Short Interest Trends Recently, Humana Inc (NYSE: HUM) has reported a notable decline in its short percent of float, decreasing by 6.3% since the previous report. As of now, the company has approximately 4.30 million shares sold short, which constitutes about 3.57% of the total shares available for trading. Based on the current trading volumes, it...

Continue Reading
Innovative Restaurant Launch Featuring AI Robots Opens Soon

Updated Category News Views 344

AI-Driven Restaurant Opening at Walmart Supercenter In an exciting development for the dining industry, Richtech Robotics Inc. (NASDAQ: RR), a leader in AI-driven service robots, has joined forces with Ghost Kitchens America to unveil their latest One Kitchen restaurant. This location, situated within a Walmart Supercenter, is marking a significant milestone as it becomes...

Continue Reading
Choosing the Perfect MySmile Teeth Whitening Solution for You

Updated Category News Views 82

Your Guide to MySmile Teeth Whitening Products Achieving a whiter, brighter smile is easier than ever with MySmile's effective teeth whitening solutions. MySmile offers a range of products tailored to fit different lifestyles; whether you're interested in an all-in-one kit, convenient whitening strips, or one-step solutions, the right product is just a choice away. Let's...

Continue Reading